Molina-Cerrillo, J.; Marquet-Palomanes, J.; Alonso-Gordoa, T.; López-Jiménez, J.; Grande, E.
May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic Leukemia. Healthcare 2021, 9, 78.
https://doi.org/10.3390/healthcare9010078
AMA Style
Molina-Cerrillo J, Marquet-Palomanes J, Alonso-Gordoa T, López-Jiménez J, Grande E.
May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic Leukemia. Healthcare. 2021; 9(1):78.
https://doi.org/10.3390/healthcare9010078
Chicago/Turabian Style
Molina-Cerrillo, Javier, Juan Marquet-Palomanes, Teresa Alonso-Gordoa, Javier López-Jiménez, and Enrique Grande.
2021. "May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic Leukemia" Healthcare 9, no. 1: 78.
https://doi.org/10.3390/healthcare9010078
APA Style
Molina-Cerrillo, J., Marquet-Palomanes, J., Alonso-Gordoa, T., López-Jiménez, J., & Grande, E.
(2021). May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic Leukemia. Healthcare, 9(1), 78.
https://doi.org/10.3390/healthcare9010078